Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06915285Completed

Automated Detection of Malarial Retinopathy in Patients Diagnosed With Cerebral Malaria

Role: lead

NCT03069729Completed

Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)

Role: lead

NCT03912961Completed

The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study

Role: collaborator

NCT01614327Completed

Computer-based Screening for Diabetic Retinopathy

Role: lead

All 4 trials loaded